ESR1 and breast neoplasm: Approximately 70% of breast tumors are estrogen receptor alpha (ER)-positive and these tumors usually depend on estrogen for growth [2]; thus, ER-targeted endocrine therapies are useful for the treatment of patients with ER+ breast tumors [3].